People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology ...
21 hours ago
0
1
The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials.
22 hours ago
0
0
If a patient is successfully resuscitated after a cardiac arrest and circulation resumes, they are not out of the woods yet. A number of factors can influence whether and how they survive the trauma in the subsequent recovery ...
22 hours ago
0
0
Nursing homes in disadvantaged communities are more likely to overmedicate residents with antipsychotics, especially homes that are understaffed, according to a study published in JAMA Network Open.
Apr 24, 2024
1
13
Semaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabetes. It works by stimulating the production of insulin to keep blood sugar levels in check.
Apr 24, 2024
0
1
New research suggests psilocybin has similar side effects to traditional antidepressants. Commonly referred to as "magic mushrooms," psilocybin is a promising alternative treatment for people with medication-resistant depression ...
Apr 23, 2024
0
56
A study has found there are no adverse long-term cardiovascular health consequences for the now-adult children of mothers who were given corticosteroids because they were at risk of early birth in a landmark trial conducted ...
Apr 23, 2024
0
68
Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.
Apr 23, 2024
0
25
For longer-term nursing home residents, initiation of antihypertensive medication is associated with an increased risk for fractures and falls, according to a study published online April 22 in JAMA Internal Medicine.
Apr 23, 2024
0
0
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) ...
Apr 23, 2024
0
1
